Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
The response to all three agents was comparable, with 75%, 72% and 70% achieving an ACR20 response at 1 year with infliximab, adalimumab and etanercept, respectively
It carries the strongest evidence base because most published protocols describe this exact schedule
Shelf life is supplier-specific and formulation-dependent
Your Journey Our medical team guides you through every stepfrom initial consultation to ongoing optimization
Controlled Use: Intended exclusively for analytical and in-vitro research environments
Some are packaged as dietary supplements where the laws are clear against the sale of these substances
US$ 22.75
US$ 28.40
US$ 24.49
US$ 27.80
US$ 24.43
US$ 23.68
US$ 27.67
US$ 22.23
US$ 21.58
US$ 27.22
US$ 26.40
US$ 26.18
US$ 22.50
